Pipeline

Next-Generation Immunotherapeutic Agents

The tumor microenvironment (TME) is the environment around a tumor,
including the surrounding blood vessels, immune cells, fibroblasts, signaling molecules and the extracellular matrix (ECM).
Tumors can change them favorable to help their initiation, growth, evolution and moving.
Our next-generation immuno-therapeutics are designed to reprogram the tumor microenvironment being unfavorable for cancer progression and at the same time to boost anti-cancer immunity to cure cancer effectively.

Survival(%)
Time
Conventional chemotheraphy
Targeted
theraphy
Immunotheraphy
Next-generation Immunotherapy
Multi-mechanism anti-cancer agents